Apolipoprotein CIII predicts cardiovascular events in patients with coronary artery disease: a prospective observational study

Table 3 Correlation of apoCIII concentration in chylomicron-free serum fasting and postprandial with baseline characteristics and other lipid parameters

	Fasting		Postprandial
	R	P value	R	P value
Clinical characteristics
Age	−0.18	0.012	−0.15	0.041
Body mass index	0.20	0.005	0.21	0.004
Clinical chemistry parameters in native serum
Fasting glucose	0.39	< 0.001	0.32	< 0.001
HOMA index	0.05	0.520	0.07	0.369
HbA1c	0.12	0.098	0.14	0.064
C-reactive protein	−0.11	0.151	−0.08	0.287
Total cholesterol	0.36	< 0.001	0.294	< 0.001
LDL cholesterol	0.14	0.061	0.08	0.301
HDL cholesterol	−0.08	0.263	− 0.07	0.378
Non-HDL cholesterol	0.39	< 0.001	0.32	< 0.001
Remnant cholesterol	0.68	< 0.001	0.63	< 0.001
Fasting triglycerides	0.68	< 0.001	0.63	< 0.001
Lipid parameters in lipoprotein subfractions
Total cholesterol in CFS	−0.09	0.223	0.01	0.933
Triglycerides in CFS	0.24	0.001	0.31	< 0.001
Chylomicron cholesterol	0.46	< 0.001	0.36	< 0.001
Chylomicron triglycerides	0.67	< 0.001	0.53	< 0.001
VLDL cholesterol	−0.08	0.275	0.16	0.024
VLDL triglycerides	0.18	0.012	0.29	< 0.001
LDL cholesterol	−0.13	0.076	−0.08	0.278
LDL triglycerides	0.08	0.303	0.05	0.469
HDL cholesterol	0.20	0.006	0.21	0.003
HDL triglycerides	0.30	< 0.001	0.28	< 0.001

R: Pearson correlation coefficient, HOMA homeostasis model assessment, CFS: chylomicron-free serum

ISSN: 1476-511X